(function(){var loadHandler=window['sl_{8824A113-B472-4E24-968F-C628FF6E319A}'];loadHandler&&loadHandler(19, '<div id="spr0_39ddc8"><div id="spr1_39ddc8" class="kern"><img id="img2_39ddc8" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_39ddc8"><img id="img0_39ddc8" src="data/img0.png" width="960" height="540" alt=""/></div></div><div id="spr2_39ddc8" class="kern"><div id="spr4_39ddc8" style="left:20.736px;top:124.177px;"><img id="img1_39ddc8" src="data/img34.png" width="897" height="87" alt="" style="left:-0.001px;top:-0.035px;"/></div><div id="spr5_39ddc8" style="left:22.818px;top:258.66px;"><div style="width:0px;"><span id="txt0_39ddc8" class="nokern relpos" style="left:7.2px;top:7.107px;"></span><span id="txt1_39ddc8" class="relpos" style="left:15.011px;top:0.311px;">In high-risk patients, starting with EUS might be a preferred strategy,</span></div><div style="width:0px;"><span id="txt2_39ddc8" class="relpos" style="left:28.7px;top:31.511px;">as 48% of patients have negative studies.</span></div></div><div id="spr6_39ddc8" style="left:321.242px;top:443.512px;"><div style="width:0px;"><span id="txt3_39ddc8" class="relpos" style="left:7.2px;top:5.354px;">Journal of Gastroenterology and Hepatology 23 (2008) 741–745</span></div></div></div></div>');})();